Sacubitril/valsartan in COVID-19 patients: the need for trials

被引：11
|
作者：
Acanfora, Domenico [1 ]
Ciccone, Marco Matteo [2 ]
Scicchitano, Pietro [2 ,3 ]
Acanfora, Chiara [1 ,4 ]
Casucci, Gerardo [1 ]
机构：
[1] San Francesco Hosp, Unit Internal Med, Viale Europa 21, I-82037 Telese Terme, BN, Italy
[2] Univ Bari, Sch Med, Sect Cardiovasc Dis, Dept Emergency & Organ Transplantat, Bari, Italy
[3] Hosp F Perinei Altamura, Cardiol Unit, Bari, Italy
[4] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2020年 / 6卷 / 04期
关键词：
D O I：
10.1093/ehjcvp/pvaa044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [31] Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
    Teh, Jiasian
    O'Connor, Ellen
    Coles-Black, Jasamine
    Lawrentschuk, Nathan
    WORLD JOURNAL OF UROLOGY, 2021, 39 (09) : 3147 - 3149
  • [32] Evaluating treatment efficacy in hospitalized COVID-19 patients, with applications to Adaptive COVID-19 Treatment Trials
    Lin, Dan-Yu
    Wang, Jianqiao
    Gu, Yu
    Zeng, Donglin
    CLINICAL TRIALS, 2024, 21 (04) : 500 - 506
  • [33] Experience of using sacubitril - valsartan in dialysis patients
    Galvan Ruiz, M. Mario
    De Sanmamed Giron, M. Fernandez
    Lopez Perez, M.
    Groba Marco, M.
    Singh, M.
    Martin Bou, E.
    Andrades Guerra, R.
    Sanchez Perez, A.
    Cardenes Leon, A.
    Pena Ortega, P.
    Rua-Figueroa Erausquin, D.
    Gil, J. M. Medina
    Benitez Pena, J.
    Caballero Dorta, E.
    Garcia Quintana, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 119 - 120
  • [34] THE EFFECT OF SACUBITRIL/VALSARTAN TREATMENT ON HYPERTENSIVE PATIENTS
    Nozato, Yoichi
    Takami, Yoichi
    Takahashi, Toshimasa
    Fujimoto, Taku
    Yoshida, Shino
    Hongyo, Kazuhiro
    Koriyama, Hiroshi
    Akasaka, Hiroshi
    Rakugi, Hiromi
    Yamamoto, Koichi
    JOURNAL OF HYPERTENSION, 2024, 42 (SUPPL 3)
  • [35] Use of sacubitril - valsartan in octogenarian patients.
    Galvan Ruiz, M. Mario
    De Sanmamed Giron, M. Fernandez
    Singh, M.
    Groba Marco, M. V.
    Davila Ramos, M.
    Lopez Perez, M.
    Mendoza Lemes, H.
    Martin Lorenzo, P.
    Blanco Nuez, M.
    Suarez Perez, I.
    Bonilla Fernandez, J. A.
    Escobar Gonzalez, M.
    Medina Gil, J. M.
    Caballero Dorta, E.
    Garcia Quintana, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 80 - 80
  • [36] Stroke Patients Without COVID-19 Symptoms Is There a Need to Screen?
    Tan, You-Jiang
    Narasimhalu, Kaavya
    Chan, Yvonne
    De Silva, Deidre A.
    NEUROLOGIST, 2021, 26 (02) : 73 - 74
  • [37] Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?
    Moretto, F.
    Sixt, T.
    Devilliers, H.
    Abdallahoui, M.
    Eberl, I
    Rogier, T.
    Buisson, M.
    Chavanet, P.
    Duong, M.
    Esteve, C.
    Mahy, S.
    Salmon-Rousseau, A.
    Catherine, F.
    Blot, M.
    Piroth, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 256 - 260
  • [38] Sacubitril/Valsartan in hemodialysis patients with heart failure
    Michel, Anne
    Schmid, Andreas
    Burkhalter, Felix
    SWISS MEDICAL WEEKLY, 2021, 151 : 40S - 40S
  • [39] Correction: The unmet need for COVID-19 treatment in immunocompromised patients
    Alessandra D’Abramo
    Serena Vita
    Emanuele Nicastri
    BMC Infectious Diseases, 23
  • [40] Statistical method to determine the need for hospitalization of COVID-19 patients
    Vasconcelos, Fernando Freire
    de Moura, Heber Jose
    REVISTA DE ADMINISTRACAO PUBLICA, 2020, 54 (05): : 1417 - 1428
12345